We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Tailored Interactive Website for Promoting Condom Use Among Young Adults (Youthnet)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00183638
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : November 27, 2013
Sponsor:
Collaborator:
Information provided by (Responsible Party):

Study Description
Brief Summary:
This study will develop and evaluate the effectiveness of tailored web-based messages in promoting condom use among young adults.

Condition or disease Intervention/treatment Phase
HIV Infections Sexually Transmitted Diseases Behavioral: Internet-based tailored prevention messages Behavioral: Non-tailored messages Phase 2

Detailed Description:

Adolescents and young adults are at the greatest risk for acquiring a sexually transmitted disease (STD). Approximately 3 million people between the ages of 18 and 24 become infected with an STD each year. Education about the risks and consequences of unprotected sex is a powerful tool that can be used to prevent or reduce the risk of infection. The program in this study will deliver messages to educate participants about condom use and the risk of STD infection. The study will evaluate the effectiveness of a tailored interactive online risk reduction program versus a standard online risk reduction program in reducing the risk of STD infection in young adults.

Participants in this open-label study will be recruited from one of two clinics in the Denver, Colorado area: Denver Metropolitan Health Clinic or Planned Parenthood of the Rocky Mountains. Participants will be randomly assigned to receive internet-based messages from either the Youthnet program or the control program while filling out a risk assessment survey. Participants in the Youthnet program will be asked their gender and ethnicity so they may be assigned to a role model of the same gender and ethnicity via a computer program. This role model will appear online 5 times during the survey to deliver interactive messages that will be tailored to HIV/STD risk reduction and will specifically address attitudes about condom usage. The control program will deliver 5 general, non-tailored messages containing information on reproductive health not specific to condoms or STDs. Participants will be assessed at baseline and a follow-up session 3 months after enrollment. Frequency of condom use and attitudes toward condom use will be assessed using behavioral scales.


Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 1870 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Randomized Controlled Trial to Establish Efficacy of a Website to Promote Condom Use for Adults Aged 18-25
Study Start Date : June 2003
Primary Completion Date : December 2008
Study Completion Date : December 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: 1
Participants will receive Internet-based tailored prevention messages
Behavioral: Internet-based tailored prevention messages
Participants will receive five 30-second flash clips promoting condom norms, positive attitudes, self-efficacy, and risk awareness. Participants in the Youthnet program will be asked their gender and ethnicity so they may be assigned to a role model of the same gender and ethnicity via a computer program. This role model will appear online 5 times during the survey to deliver interactive messages that will be tailored to HIV/STD risk reduction and will specifically address attitudes about condom usage.
Other Name: Youthnet
Active Comparator: 2
Participants will receive non-tailored messages containing information on reproductive health
Behavioral: Non-tailored messages
The control program will deliver five general, non-tailored messages containing information on reproductive health not specific to condoms or STDs.


Outcome Measures

Primary Outcome Measures :
  1. Condom use with non main partners [ Time Frame: Measured at Month 3 ]

Secondary Outcome Measures :
  1. Self-efficacy for condom use and condom negotiation [ Time Frame: Measured at Month 3 ]
  2. Attitudes and norms towards condom use [ Time Frame: Measured at Month 3 ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 25 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Client of Denver Metropolitan Health Clinic or Planned Parenthood
  • English-speaking
  • Access to a computer and an existing e-mail account
  • Will be in Denver for at least 4 months

Exclusion Criteria:

  • Not a resident of the Denver metropolitan area
  • No existing e-mail address
  • No access to a computer
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00183638


Locations
United States, Colorado
University of Colorado Health Sciences Center
Aurora, Colorado, United States, 80045-0508
Sponsors and Collaborators
University of Colorado, Denver
National Institute of Mental Health (NIMH)
Investigators
Principal Investigator: Sheana S. Bull, PhD University of Colorado, Denver
More Information

Responsible Party: University of Colorado, Denver
ClinicalTrials.gov Identifier: NCT00183638     History of Changes
Other Study ID Numbers: 02-0764a
R01MH063690 ( U.S. NIH Grant/Contract )
DAHBR 9A-ASI
First Posted: September 16, 2005    Key Record Dates
Last Update Posted: November 27, 2013
Last Verified: November 2013

Keywords provided by University of Colorado, Denver:
Internet
Interactive Computer Program
HIV Prevention

Additional relevant MeSH terms:
HIV Infections
Sexually Transmitted Diseases
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Immunologic Deficiency Syndromes
Immune System Diseases
Infection
Genital Diseases, Male
Genital Diseases, Female